Bal Pharma: Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31.12.2025.

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended 31.12.2025.